Ruiying Asset Management
VC Fund
Shenzhen, China
Ruiying Asset Management is a VC fund in Shenzhen focused on Medical and Biopharma. Ruiying Assets is an Asset Management firm
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ruiying Asset Management invests in
Stages Ruiying Asset Management invests in
Countries Ruiying Asset Management invests in
Investment Focus
Industry
- Medical 2 (67%)
- Biopharma 2 (67%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Series B 2 (67%)
- Series A 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases. | $1.5K / Series B / Apr 23, 2023 | |
|
|
Biosun Pharma is an innovative biopharmaceutical company that specializes in the production of drugs for tumors, self-immune diseases, and inflammatory diseases. | Series B / Jan 09, 2023 | |
|
|
Arthur Pharmaceuticals is a high-tech innovative pharmaceutical manufacturer. | Series A / Apr 06, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ruiying Asset Management invest in?
Ruiying Asset Management invests primarily in Medical, Biopharma and Biotechnology startups, most often at Series B and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ruiying Asset Management last invest?
The most recent investment recorded for Ruiying Asset Management closed in Apr 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!